Earnings Analyzer
Stock earnings page

AllianceBernstein Holding L.P. (AB)

Track the next or latest earnings date for AllianceBernstein Holding L.P., review consensus estimates, and see cached AI analysis for recent quarterly results.

Recent earnings news

Hexagon AB stock (SE0015961909): Q1 2026 earnings and strategy keep investors watching
www.ad-hoc-news.de · 1 day ago

Hexagon AB has reported Q1 2026 results and confirmed its focus on software-driven industrial and geospatial solutions, while the share has shown only moderate moves recently. What matters now for investors following the Swedish tech group?

Atlas Copco AB stock (SE0011166610): earnings momentum keeps compressor specialist in focus
www.ad-hoc-news.de · 2 days ago

Atlas Copco AB remains a core name in compressors and vacuum solutions. Strong quarterly results and

Exploring Analyst Estimates for Abercrombie (ANF) Q1 Earnings, Beyond Revenue and EPS
finance.yahoo.com · 2 days ago

Empirical studies consistently ... of a stock. While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding. With that in mind,…

SKF AB stock (SE0000108227): shares edge higher after Q1 2026 earnings and cautious industrial outlo
www.ad-hoc-news.de · 1 day ago

Following the Q1 2026 earnings release, SKF AB’s B share on Nasdaq Stockholm posted modest gains, with the stock trading around SEK 255 on 04/24/2026, up approximately 1.8 percent compared with the pre-results close, according to price data from Nasdaq Stockholm as of 04/24/2026 cited by ...

AbbVie Inc stock (US00287Y1091): new data, dividend strength and oncology focus draw investor attent
ad-hoc-news.de · 2 days ago

What the latest news means for the pharma heavyweight’s stock narrative. ... AbbVie Inc remains in focus after a series of recent pipeline and regulatory updates, alongside its well-established dividend profile, kept the biopharma group in the headlines. The company is navigating the post-Humira era…

Latest earnings date

Feb 05, 2026

Time not specified

Fiscal quarter: 2025-12-31

EPS estimate: $0.95

Revenue estimate: N/A

Market cap: $3.29B

Analysis snapshot

No cached AI earnings analysis is available for this stock yet. Check back after the company reports or open the app to generate a fresh analysis.

Recent earnings history

Browse the calendar week
Date Quarter Report window EPS est. Revenue est.
Feb 05, 2026 2025-12-31 Time not specified $0.95 N/A